QA: Quidelortho Corp in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001906324_2023_Quidelortho_Corp.pdf

Logs

warning Missing logo subcommand.report {}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001906324, Quidelortho Corp

  xvar xval
0 LiabilitiesNoncurrent 177,100,000
1 LiabilitiesCurrent 323,500,000
2 remainder_Liabilities 400,000
3 AssetsCurrent 1,440,300,000
4 AssetsNoncurrent 185,100,000
5 PropertyPlantAndEquipmentNet 349,200,000
6 Goodwill 435,700,000
7 remainder_Assets 20,100,000
8 GeneralAndAdministrativeExpense 239,600,000
9 ResearchAndDevelopmentExpense 95,700,000
10 remainder_Expenses 653,400,000
11 remainder_Revenues 1,698,600,000
12 remainder_NetIncome -5,700,000
13 remainder_ComprehensiveNetIncome 800,000
  yvar yval
0 Liabilities 501,000,000
1 Assets 2,430,400,000
2 Expenses 988,700,000
3 Revenues 1,698,600,000
4 StockholdersEquity 1,929,400,000
5 NetIncome 704,200,000
6 ComprehensiveNetIncome 704,600,000
7 BaseVar 2,812,600,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.28
9 EconomicCapitalRatio 2.55

Edgar->Model Mapping

Feature Distribution